Uveitis
201
15
25
107
Key Insights
Highlights
Success Rate
83% trial completion
Published Results
39 trials with published results (19%)
Research Maturity
107 completed trials (53% of total)
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
10.9%
22 terminated out of 201 trials
82.9%
-3.6% vs benchmark
21%
42 trials in Phase 3/4
36%
39 of 107 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 107 completed trials
Clinical Trials (201)
A Study of Uveitis in Children <18 Years of Age
Uveitis/Intraocular Inflammatory Disease Biobank (iBank)
Intestinal Bacteria and Ocular Inflammatory Disease
RChildUV:Study on Non-infectious Chronic Uveitis in Pediatric Age
Genetics of Uveitis
Imaging Quantification of Inflammation (IQI)
Analysis of Anterior Chamber Inflammation by Optical Coherence Tomography
Imaging of Uveitis Patients Receiving Injectable Fluocinolone Acetonide Implant
Evaluation of the Switch From the Original Infliximab to Its Biosimilar in Daily Practice at Cochin Hospital
A Study of Brepocitinib in Adults With Active, Non-Infectious, Non-Anterior Uveitis
Wide Field OCTA in Ocular Diseases
ACTH as A Re-emerging theRapy for Uveitis (The ACTHAR Study)
Targeting Immunosuppressive Treatment for Non-infectious Uveitis Using Aqueous Humor Cytokine Profiles
Metagenomics for Ocular Inflammation
Demographics and Clinical Characteristics of Ocular Inflammatory Diseases in Singapore
Randomized Trial Comparing Efficacy of Adalimumab, Anakinra and Tocilizumab in Non-infectious Refractory Uveitis
Effect of Adalimumab for the Treatment of Uveitis in Juvenile Idiopathic Arthritis
Evaluation of a Standardized Strategy for Uveitis Etiological Diagnosis
The Use of Two YUTIQ Versus Sham for Treatment of Chronic Non Infectious Intraocular Inflammation Affecting the Posterior Segment
Characteristics of Ankylosing Spondylitis Associated Uveitis